Skip to main content
. 2022 Mar 27;14(4):720. doi: 10.3390/pharmaceutics14040720

Table 1.

Biodistribution (% injected dose) of 177Lu2O3-iPSMA in CD1 mice at various time points (mean ± SD) (n = 3) after intravenous injection.

Organ Time (h)
3 48 72 96
Heart 0.11 ± 0.03 0.08 ± 0.02 0.02 ± 0.01 0.01 ± 0.01
Liver 23.56 ± 2.13 18.08 ± 0.94 16.87 ± 1.37 14.59 ± 1.72
Lung 0.34 ± 0.32 0.21 ± 0.15 0.16 ± 0.09 0.12 ± 0.05
Pancreas 0.12 ± 0.04 0.04 ± 0.03 0.01 ± 0.01 0.00 ± 0.00
Spleen 1.61 ± 0.59 1.18 ± 0.91 0.99 ± 0.63 0.81 ± 0.35
Kidney 0.85 ± 0.11 0.41 ± 0.18 0.22 ± 0.07 0.19 ± 0.10
Brain 0.01 ± 0.01 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00